ENO1 and pancreatic neoplasm: In our previous report, we demonstrated that ENO1 cell surface expression is important for plasminogen-dependent invasion, and that targeting of ENO1 with a monoclonal antibody inhibits the invasiveness of pancreatic cancer cells [12].